Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 24;18(1):111.
doi: 10.1186/s13223-022-00749-0.

Novel PGM3 mutation in two siblings with combined immunodeficiency and childhood bullous pemphigoid: a case report and review of the literature

Affiliations

Novel PGM3 mutation in two siblings with combined immunodeficiency and childhood bullous pemphigoid: a case report and review of the literature

Mazdak Fallahi et al. Allergy Asthma Clin Immunol. .

Abstract

Background: Bullous pemphigoid is the most common autoimmune subepidermal blistering disorder with a low incidence in childhood. Combined immunodeficiencies (CIDs) are a group of monogenic inborn errors of immunity (IEIs) characterized by T- and B-cell dysfunction leading to recurrent infections, lymphoproliferation, predisposition to malignancy, and autoimmunity. Here, we report two Afghan siblings with a diagnosis of CID and extremely rare manifestation of diffuse bullous pemphigoid skin lesions.

Case presentation: The older sibling (patient 1) was a 32-month-old male with facial dysmorphism, protracted diarrhea, failure to thrive, recurrent oral candidiasis, recurrent otitis media with tympanic membrane perforation, who had been previously diagnosed with CID. While he was under treatment with intravenous immunoglobulin (IVIg), he developed extensive blistering lesions, which were diagnosed as childhood bullous pemphigoid. Methylprednisolone and azathioprine were added to the regimen, which resulted in a remarkable improvement of the skin lesions and also the feeding condition. However,2 weeks later, he was re-admitted to the intensive care unit (ICU) and eventually died due to fulminant sepsis. Later, his 12-month-old sister (patient 2) with similar facial dysmorphism and a history of developmental delay, food allergy, recurrent oral candidiasis, and respiratory tract infections also developed blistering skin lesions. She was under treatment for occasional eczematous lesions, and had been receiving IVIg for 3 months due to low levels of immunoglobulins. Further immunologic workup showed an underlying CID and thus treatment with IVIg continued, gradually improving her clinical condition. The genetic study of both siblings revealed a novel homozygous mutation in exon 7 of the PGM3 gene, c.845 T > C (p.Val282Ala).

Conclusions: Dermatologic disorders may be the presenting sign in patients with CID and mutated PGM3. This case report further extends the spectrum of skin manifestations that could be observed in PGM3 deficiency and emphasizes the importance of considering CIDs during the assessment of skin disorders, particularly if they are extensive, recurrent, refractory to treatment, and/or associated with other signs of IEIs.

Keywords: Blister; Case report; Inborn errors of immunity; PGM3 deficiency; Skin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Diffuse bullous lesions in patient 1 A and 2 B
Fig. 2
Fig. 2
The histopathologic findings of skin lesions. a Subepidermal blister which appears intraepidermal located at the periphery as a result of epithelial regeneration. The blister is filled with many red blood cells and small number of neutrophils, eosinophils and lymphocytes, H&E × 200. b Periodic acid Schiff (PAS) positive basement membrane is focally presented at the base of the subepidermal blister, PAS × 400
Fig. 3
Fig. 3
The family pedigree and chromatograms. Sanger sequencing confirmed a homozygous missense variant (c.845 T > C, p.Val282Ala) in exon 7 of the PGM3 gene in the index patient A. The mother B and father C were heterozygous for the variant. Squares, male; circle, female; solid symbols, affected subjects; slashed symbol, deceased subject

References

    1. Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management. Clin Rev Allergy Immunol. 2018;54(1):26–51. doi: 10.1007/s12016-017-8633-4. - DOI - PubMed
    1. Witte M, Zillikens D, Schmidt E. Diagnosis of autoimmune blistering diseases. Front Med. 2018;5:296. doi: 10.3389/fmed.2018.00296. - DOI - PMC - PubMed
    1. Egami S, Yamagami J, Amagai M. Autoimmune bullous skin diseases, pemphigus and pemphigoid. J Allergy Clin Immunol. 2020;145(4):1031–1047. doi: 10.1016/j.jaci.2020.02.013. - DOI - PubMed
    1. Chou C-S. Childhood bullous pemphigoid: a case report and literature review. J Clin Exp Dermatol Res. 2014 doi: 10.4172/2155-9554.S6-010. - DOI
    1. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40(1):24–64. doi: 10.1007/s10875-019-00737-x. - DOI - PMC - PubMed

LinkOut - more resources